CDXS Codexis Inc

Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.

$24.02  -0.60 (-2.44%)
As of 04/09/2021 15:59:49 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/22/2010
Outstanding shares:  64,400,716
Average volume:  692,450
Market cap:   $1,545,617,184
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    192005106
ISIN:        US1920051067
Sedol:      B5LL2C2
Valuation   (See tab for details)
PE ratio:   -64.37
PB ratio:   9.07
PS ratio:   22.38
Return on equity:   -14.11%
Net income %:   -34.77%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy